Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

523
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

920
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
920
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Development of a Patient-Level Multi-objective Optimisation Model for Screening Strategies for Childhood Type 1 Diabetes.

PharmacoEconomics·2026
Same author

Screening and monitoring for presymptomatic type 1 diabetes: a time for action.

Hormone research in paediatrics·2026
Same author

Integrating a Research-Based Type 1 Diabetes Autoantibody Screening Protocol into an Economically and Culturally Diverse Federally Qualified Health Center.

Academic pediatrics·2026
Same author

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same author

Determinants of Infant Participation and Non-Participation in Primary Prevention Trials.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same author

Differences in immune cell profiles around the time of islet autoimmunity seroconversion in children with and without type 1 diabetes.

BMJ open diabetes research & care·2026

Related Experiment Video

Updated: Jun 24, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles.

Mohamed Ghalwash1,2, Vibha Anand3, Kenney Ng1

  • 1T.J. Watson Research Center, IBM, Yorktown Heights, NY.

Diabetes Care
|June 11, 2024
PubMed
Summary

Distinct islet autoantibody profiles predict type 1 diabetes progression. Early IAA, GADA, and IA-2A emergence in children indicates the highest diabetes risk, aiding early intervention strategies.

More Related Videos

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.5K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.5K

Related Experiment Videos

Last Updated: Jun 24, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K
Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.5K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.5K

Area of Science:

  • Endocrinology
  • Immunology
  • Pediatrics

Background:

  • Type 1 diabetes (T1D) arises from autoimmune destruction of pancreatic beta cells.
  • Islet autoantibodies are key biomarkers for T1D prediction and staging.
  • Understanding autoantibody profiles can refine risk stratification and prevention strategies.

Purpose of the Study:

  • To characterize distinct islet autoantibody profiles preceding stage 3 T1D.
  • To correlate specific autoantibody sequences and timing with T1D progression rates.

Main Methods:

  • Utilized data from 1,845 genetically susceptible children in the T1DI study.
  • Applied a novel similarity algorithm for unsupervised hierarchical clustering of autoantibody profiles (IAA, GADA, IA-2A).
  • Analyzed temporal autoantibody data, age at seroconversion, and autoantibody variation.

Main Results:

  • Identified five distinct autoantibody profile clusters.
  • Children with early IAA, followed by GADA and IA-2A, showed the highest 5-year T1D risk (69.9%).
  • Persistent IAA/GADA (39.1%) and GADA/IA-2A (30.9%) also indicated high risk; single autoantibody positivity had the lowest risk (1.6%).

Conclusions:

  • A novel clustering algorithm effectively identified distinct islet autoantibody profiles and associated T1D progression rates.
  • These findings aid in predicting T1D development and selecting participants for prevention trials.
  • The study provides insights into diverse autoimmune pathways leading to T1D.